19-ETF Watchlist — Full Diagnostic

All data as of Apr 30, 2026. Prices in EUR unless noted. TradingView tickers provided per ETF. No price predictions — thesis + conditions only.

Capital Available
€860.31
Grandfather Tranche 1 — TradeRepublic
Cleared for Entry
3 / €645
€215 each — protocol cleared
Cash Reserve
€215
4th tranche — no thesis identified
Next Unlock Target
~€946
+10% portfolio growth
VIX (current)
18.64
Entry permitted · Normal range
DXY (current)
98.35
Weakening → EUR positions favoured

Cleared for Entry

Protocol Cleared Deploy Now
VanEck Defense UCITS ETF
IE000YYE6WK5  ·  Cleared
TradingView: DFEN.DE (EUR/Xetra)
alt: DFNS.L (USD/LSE)
What It Is
IndexMarketVector Global Defense Industry
Holdings~100
TER0.55% p.a.
AUM€7.27B
ReplicationFull physical
TypeAccumulating — no dividends paid out
LaunchMar 2023
DomicileIreland (UCITS)
Geographic Exposure
US ~57% EU ~33% UK ~5% Other ~5%
Top Holdings
LMTRTXNOC GDBAE SystemsRheinmetall L3HarrisTransDigmLeonardo

No single company typically >10%. Diversified across US & European primes.

Price Context (EUR, DFEN.DE)
52W Low€44.14
52W High€64.51
Current (Apr 30)~€55.80
From 52W High−13.5%
Position in Range57%
€44.14
€64.51

Pulled back ~13.5% from 52W high. Mid-range entry. YTD return still strong (+65% over prior year from low).

Thesis
Permanent reset of global defense spending. NATO expansion from Cold War averages (~1.5% GDP) toward 3–5% GDP. Germany's Zeitenwende (€100B+ defense budget reversal). Middle East instability, Hormuz blockade, Russia-Ukraine entrenchment. Defense budgets are sticky — they go up in crises and don't come back down. Timeframe: 5–10 years structural. 1–3 years momentum.
Thesis Breakers
  • Comprehensive peace settlement Russia-Ukraine + genuine Hormuz reopening simultaneously
  • Major European recession forcing austerity cuts to defense commitments
  • US withdrawal from NATO triggering European budget uncertainty
  • Arms control treaty limiting procurement (low probability near-term)
Macro Sensitivity
DriverEffect
Geopolitical escalation↑ Strong
NATO budget announcements↑ Strong
US defense budgets↑ Strong
Peace negotiations↓ Sharp
Rate hikes (discounts future earnings)↓ Mild
USD/EUR (30% of holdings in EUR)Mixed
Overlap with Watchlist

Aerospace/defense names appear in:

STOXX 600 (~3%) DAX (Airbus ~5%) MSCI World (~1.5%)

Practically independent. No meaningful overlap with any core or tech ETF. This is a pure defense bet.

Action
Entry — Protocol Cleared

Deploy €215. VIX 18.64 — entry permitted. Pullback from ATH creates reasonable entry. Watch DFEN.DE on TradingView. No stop required for long-term thesis, but if price drops below €44 (52W low), reassess.

Maintenance Cadence

Daily: geopolitical headlines (Hormuz, NATO). Weekly: sector price vs. benchmark. Quarterly: review NATO budget commitments and order books of top holdings.

iShares Healthcare Innovation UCITS ETF
IE00BYZK4776  ·  Cleared
TradingView: HEAL.MI (EUR/Milan)
alt: 2B78.DE (USD/Xetra)
What It Is
IndexiSTOXX FactSet Breakthrough Healthcare
Holdings~100
TER0.40% p.a.
AUM€831M
ReplicationSampling
TypeAccumulating
LaunchSep 2016
DomicileIreland (UCITS)
Sector Exposure
Medical Devices ~30% Biotech ~25% Diagnostics ~20% Digital Health ~15% Genomics ~10%
US ~75% Europe ~15% Other ~10%
Top Holdings
Intuitive SurgicalDexcom ResMedInsulet Align TechnologyVeeva Systems CRISPR Therapeutics
Price Context (USD, HEAL.L)
52W Low~$6.43
52W High~$9.46
NAV (Jan 7)$9.45
EUR listing (Feb 13)€7.53
NoteHealthcare had pullback Feb–Apr on GLP-1/obesity drug concerns. Verify current price in TR before entry.
Thesis
Healthcare innovation is secular — demographic aging, biotech breakthrough cycle (GLP-1, CAR-T, gene editing), remote monitoring, AI-assisted diagnostics. Decoupled from economic cycles: people get sick regardless of GDP. Long holding period absorbs near-term drug pricing noise. Timeframe: 5–10 years.
Thesis Breakers
  • US drug pricing legislation (IRA) severely capping biotech R&D returns
  • GLP-1/obesity drug disrupts medical device demand (Dexcom, Insulet directly at risk)
  • FDA approval wave reversal — increased rejection rates killing pipeline value
  • Sustained high interest rates compressing small-cap biotech valuations
Macro Sensitivity
DriverEffect
FDA approvals / trial data↑ Strong
Aging demographics↑ Structural
Rate cuts (small-cap relief)↑ Moderate
Drug pricing legislation↓ Sharp
GLP-1 device disruption↓ Some holdings
Economic recession~Neutral (healthcare demand stable)
Overlap with Watchlist
MSCI World (~14% Health) S&P 500 (~12% Health) ACWI (~11% Health)

Some overlap with broad market ETFs on sector level, but the holdings are innovation-focused (not big pharma) — very different names. Low effective overlap with core ETFs.

Action
Entry — Protocol Cleared

Deploy €215. Verify current price on HEAL.MI or 2B78.DE before executing — price may have shifted since Jan 2026. If EUR price is below €8.00, this represents a pullback from ATH — favorable entry. GLP-1 concern = short-term noise on long thesis.

Maintenance Cadence

Monthly: major FDA decisions. Quarterly: GLP-1/obesity drug impact on device holdings (Dexcom, Insulet). Annually: sector allocation review vs. demographic tailwinds.

Xtrackers MSCI World Energy UCITS ETF 1C
IE00BM67HM91  ·  Cleared
TradingView: XDW0.DE (EUR/Xetra)
alt: XDW0.L (USD/LSE)
What It Is
IndexMSCI World Energy (developed markets only)
Holdings~100
TER0.25% p.a.
AUM€1.73B
ReplicationFull physical
TypeAccumulating
LaunchMar 2016
NoteDeveloped markets only — no EM oil names
Geographic Exposure
US ~58% UK ~12% France ~9% Canada ~8% Other DM ~13%
Top Holdings
ExxonMobilChevron ShellTotalEnergies ConocoPhillipsBP EOG ResourcesSLB
Price Context (EUR, XDW0.DE)
52W Low€40.72
52W High€66.92
Current (Apr 18)~€56.72
From 52W High−15.3%
Position in Range61%
€40.72
€66.92

Hormuz closure pushed oil to $106 but ETF has pulled back ~15% from 52W high. Indicates supply disruption premium already partially priced in, with some retracement.

Thesis
Tactical thesis, not structural. Strait of Hormuz effectively closed since Feb 28 — largest supply disruption in market history per IEA. Oil at $106. Energy companies print cash at these levels. Free cash flow → buybacks → EPS growth → ETF NAV appreciation. This is a time-limited catalyst. Timeframe: 6–24 months, revisit on Hormuz status.
Thesis Breakers
  • Hormuz reopens → oil price collapses → energy stocks sell off sharply
  • Recession kills demand side → oil drops below $70 even with supply constraints
  • Saudi Arabia / OPEC opens taps to compensate, flooding market
  • Rapid EV adoption acceleration compressing demand outlook
Macro Sensitivity
DriverEffect
Oil price (primary driver)↑↑ Dominant
Hormuz status↑ Critical
USD strength (oil priced in USD)↑ Moderate
Global GDP/demand↑ Moderate
Hormuz reopens↓↓ Severe
Recession↓ Demand destruction
Overlap with Watchlist
MSCI World (~4.5% Energy) S&P 500 (~3.5% Energy) STOXX 600 (~7% Energy) ACWI (~4% Energy)

Small overlap with broad market ETFs, but at negligible weight. Effectively a pure energy position. Low correlation to tech cluster. This is a diversifying position.

Action
Entry — Protocol Cleared

Deploy €215. Current −15% from 52W high while oil catalyst remains active. This is the highest urgency of the three cleared positions given Hormuz is live. Set a mental exit review: if oil drops below $80 or Hormuz reopens, reassess position. Not a permanent hold — this is tactical.

Maintenance Cadence

Daily: oil price (Brent/WTI), Hormuz news. Weekly: XDW0.DE price vs. oil correlation. Monthly: IEA/OPEC supply reports. Exit trigger: Hormuz reopening announcement.

Core Watchlist

Phase 3+ Savings Plans Foundation Layer

These 7 ETFs are the foundation of the EU market strategy. No action in Phase 1 — analysis is for understanding and future deployment preparation. Savings plans activate Phase 3+.

iShares Core S&P 500 UCITS ETF
IE00B5BMR087  ·  Core · Phase 3+
TradingView: SXR8.DE (EUR/Xetra)
alt: CSPX.L (USD/LSE)
What It Is
IndexS&P 500 — 500 largest US companies
Holdings503 (full replication)
TER0.07% p.a. — benchmark low
AUM€119.9B — largest UCITS ETF
Sector Top WeightTechnology ~31% / Financials ~13%
TypeAccumulating
Top Holdings
AAPL ~7% MSFT ~7% NVDA ~6% AMZN ~4% GOOGL ~4% META ~3% BRK.B ~2% AVGO ~2%

Top 10 holdings represent ~33% of total weight. Heavy Magnificent 7 concentration.

Price Context (USD, CSPX.L)
52W Low$594.50
52W High$770.62
Current (Apr 30)~$766.47
From 52W High−0.5% (near ATH)
Position in Range98%
$594.50
$770.62
Thesis
The S&P 500 is the compounding machine of the 20th and 21st century. Over any 20-year period it has never delivered negative returns. This is not a trade — it is the foundation. Dollar-cost averaging via savings plan removes timing risk entirely. Role: core accumulation, decades-long hold. No active thesis required.
Thesis Breakers
  • No permanent breaker — time horizon absorbs corrections. 2000, 2008, 2020 all recovered.
  • Regulatory break-up of Magnificent 7 would reprice top 30% of holdings
  • Sustained de-dollarization shifting capital away from US equities long-term
Macro Sensitivity
DriverEffect
US corporate earnings↑ Primary
Fed rate policyMixed (cuts = ↑ usually)
USD strength vs EUR↑ NAV in USD (check EUR hedge)
Recession↓ Short-term
AI/Tech spending cycle↑ 31% tech weight
Overlap with Watchlist
MSCI World (~70% is S&P 500) ACWI (~63% is S&P 500) Nasdaq-100 (top 100 subset) S&P 500 IT (~100% overlap) S&P 500 Financials (~100%)

CRITICAL: If you hold S&P 500 + MSCI World + ACWI + Nasdaq-100 simultaneously, you own the same companies 4 times. In Phase 3, pick ONE core broad index. Don't stack all four.

Action
Phase 3+ — Savings Plan Target

Do not buy now. Near ATH. Role: monthly savings plan, Phase 3, recurring fixed amount. DCA removes ATH timing concern entirely. Current price is irrelevant for long-term savings plan logic.

Maintenance Cadence

Quarterly: review savings plan amount vs. income change. Annual: rebalance check. Nothing else needed. Set and forget.

Invesco EQQQ Nasdaq-100 UCITS ETF (Acc)
IE00BFZXGZ54  ·  Core · Phase 3+
TradingView: EQAC.MI (USD Acc/Milan)
alt: EQQU.L (USD/LSE)
What It Is
IndexNasdaq-100 — 100 largest non-financial Nasdaq stocks
Holdings102 (full replication)
TER0.30% p.a.
AUM~€8.3B (EQAC share class)
Sector Top WeightTechnology ~60% / Consumer Discret ~17%
Key RuleNo financials — banks excluded from index
Top Holdings
AAPL ~9% MSFT ~8% NVDA ~8% AMZN ~6% GOOGL ~5% META ~5% COST ~3% TSLA ~3%

Higher concentration than S&P 500. Top 10 ≈ 50%+ of total weight. More volatile, more upside in bull markets, more downside in corrections.

Price Context (USD, EQQU.L)
52W Low$400.00
52W High$651.30
Current (Apr 30)~$624.40
From 52W High−4.1%
Position in Range89%
$400.00
$651.30
Thesis vs. S&P 500 Distinction
The Nasdaq-100 is S&P 500 with leverage applied to tech. When tech cycles run hot, QQQ beats SPY. When they correct, QQQ falls harder. The choice between these two isn't about thesis — it's about risk tolerance. For a savings plan, CSPX (S&P 500) is more appropriate. EQQQ only makes sense as a deliberate overweight to tech growth over a decade.
Thesis Breakers (same as S&P 500, amplified)
  • Tech sector repricing event — any of the Magnificent 7 loses dominant market position
  • AI capex cycle ends without revenue materializing (builds P/E compression)
  • Nasdaq-100 rebalancing removing overweight winners (capping effect)
Macro Sensitivity
DriverEffect
AI investment cycle↑↑ Major
Rate cuts↑ Growth stocks re-rate
Rate hikes↓ Growth stocks de-rate
Tech earnings (AAPL/MSFT/NVDA)↑ Dominant driver
VIX spike↓ Higher beta than SPX
Overlap with Watchlist
S&P 500 (~top 100 overlap) MSCI World IT (~85% same) S&P 500 IT (~80% same) XAIX (~60% same names) SEMI (~35% same)

Highest overlap product in the watchlist. If you hold EQQQ + S&P 500 IT + XAIX, you're tripling up on NVDA, AAPL, MSFT. Check overlap map before combining.

Action
Phase 3+ — Consider vs. S&P 500

Not both. Before Phase 3 activation, decide: S&P 500 OR Nasdaq-100 as core index. Nasdaq-100 has higher return but higher volatility. For a beginner savings plan, S&P 500 is the more durable choice. Revisit this when Phase 3 activates.

Maintenance Cadence

Same as S&P 500. Quarterly earnings watch on top 5 holdings (NVDA particularly). If AI capex narrative breaks, this reacts hardest.

iShares Core MSCI World UCITS ETF
IE00B4L5Y983  ·  Core · Phase 3+
TradingView: EUNL.DE (EUR/Xetra)
alt: IWDA.L (USD/LSE)
What It Is
IndexMSCI World — ~1,400 stocks, 23 developed markets
Holdings~1,398 (full replication)
TER0.20% p.a.
AUM~€135B
GeographyUS 70% · Japan 6% · UK 4% · France 3% · Canada 3%
TypeAccumulating
MSCI World vs. S&P 500 — The Key Difference
S&P 500 is pure US. MSCI World adds Japan (Toyota, Sony, TSMC via cross-listing), UK (AstraZeneca, Shell, HSBC), France (LVMH, TotalEnergies, Hermès), Switzerland (Nestlé, Novartis, Roche), Germany (SAP, Siemens), Canada, Australia. The 30% non-US exposure provides currency diversification and different economic cycle exposure. Performance has historically been within 1–3% of S&P 500 annually.
Price Context (USD, IWDA.L)
52W Low$104.44
52W High$137.88
Current (Apr 29)~$136.03
From 52W High−1.3% (near ATH)
Position in Range95%
Role in Portfolio
The one-ETF retirement portfolio. Broadest diversification at lowest cost after CSPX. If you could only hold one ETF forever, this would be a reasonable choice — though US-heavy like S&P 500. Many European investors use IWDA as their single core holding. The slight Japan/Europe exposure vs. pure S&P 500 has minimal performance impact historically.
Thesis Breakers
  • Same as S&P 500 (70% US) plus: Japan entering prolonged deflation again, European stagflation cycle
  • USD structural weakness would erode EUR-investor returns on 70% USD-denominated exposure
Macro Sensitivity
DriverEffect
US market (70% weight)↑ Dominant
JPY/USD (Japan 6%)↓ Yen weakness hurts
EUR/USD (for EUR investor)Mixed (hedged options exist)
Global growth outlook↑ Moderate
Overlap with Watchlist
S&P 500 (70% of this) ACWI (93% of this) DAX (subset) STOXX 600 (partial)

MSCI World + S&P 500 together = massive double-counting. MSCI World + Nasdaq-100 + ACWI = triple-counting AAPL/MSFT/NVDA. Pick ONE broad core.

Action
Phase 3+ Candidate — Best Single Core

The strongest case as a single core index for EU investors. More diversified than pure S&P 500 at reasonable cost (0.20%). If Phase 3 plan is one core index, IWDA is the most defensible choice. Discuss with grandfather before Phase 3 design.

iShares MSCI ACWI UCITS ETF
IE00B6R52259  ·  Core · Phase 3+
TradingView: ISAC.DE (EUR/Xetra)
alt: SSAC.L (USD/LSE)
What It Is
IndexMSCI ACWI — 23 developed + 24 emerging markets
Holdings~2,900
TER0.20% p.a.
AUM~€26–27B
EM Exposure~10–11% (China, India, Taiwan, Korea)
TypeAccumulating
ACWI vs. MSCI World — The Difference
ACWI adds ~10% emerging market exposure on top of MSCI World. You get China (~3.5%), India (~2%), Taiwan (~2%), South Korea (~1.5%), Brazil, South Africa. The EM addition reduces US concentration from 70% to ~63%. Historically EM has had higher volatility and periods of underperformance, but India and Asia ex-China have been strong.
Price Context (EUR, ISACI)
52W Low~€76.83
52W High~€114.22
Current (Apr 8)~€110.62
From 52W High~−3.1%
NoteCheck SSAC.L/ISAC.DE for current price — Apr 8 data.
Thesis
Maximum geographic diversification in one instrument. The argument for ACWI over MSCI World is a bet that EM growth (India, SE Asia) will meaningfully contribute over the next decade. India has been cited as the strongest EM story of 2025–26. China risk is diluted at 3.5%. If you believe globalization continues, ACWI is the most complete answer.
Thesis Breakers
  • China economic collapse / property debt crisis (affects ~3.5% of ACWI directly)
  • EM currency crises dragging down NAV for EUR investor
  • Geopolitical decoupling (US/China tech war accelerating — Taiwan risk)
Macro Sensitivity
DriverEffect
US market (63% weight)↑ Dominant
EM currency movesMixed
China policy / dataModerate (3.5% weight)
India growth↑ Growing driver
USD strengthNegative for EM allocation
Overlap with Watchlist
MSCI World (93% overlap) S&P 500 (63% overlap) AMUNDI EM (11% in common)

ACWI + MSCI World + S&P 500 together is near-complete triple overlap. In Phase 3, pick ONE. ACWI is the most complete, MSCI World is simpler, S&P 500 is cheapest with highest historical return.

Action
Phase 3+ — Best if EM Conviction

Only choose this over MSCI World if you have conviction on emerging market growth (India specifically). Otherwise the EM component adds volatility without proportional return benefit. Monitor: India GDP growth, China property sector, Taiwan geopolitics.

Amundi Core STOXX Europe 600 UCITS ETF
LU0908500753  ·  Core · Phase 3+
TradingView: CS1.DE (EUR/Xetra)
alt: MEUD.PA (EUR/Euronext)
What It Is
IndexSTOXX Europe 600 — 600 European companies, 17 countries
Holdings600 (full replication)
TER0.07% p.a. — tied lowest in class
AUM~€7–8B
GeographyUK 22% · France 16% · Switzerland 14% · Germany 13%
TypeAccumulating · EUR denominated (no FX risk)
Why This vs. Other European ETFs
0.07% TER is the cheapest way to access all of Europe. Includes small, mid, large cap. The Xtrackers DAX (ETF 9) is a 40-stock concentration vs. 600 here. If you want European exposure, this is the instrument — not the DAX. Pure EUR, no dollar exposure, directly hedged to your life in Spain.
Top Holdings
ASMLNestlé Novo NordiskLVMH AstraZenecaShell TotalEnergiesSAPHSBC
Price Context (EUR — check CS1.DE)
52W RangeCheck CS1.DE in TradingView
CurrentVerify current in TR
STOXX 600 Index~520–540 range (Apr 2026)
YTD 2026Strong — Europe outperforming US in H1 2026
Thesis
European rerating thesis: Europe was significantly undervalued vs. US for years (P/E ~14x vs. US ~22x). Defense spending surge, energy transition investment, and AI catch-up investment create a multi-year earnings expansion cycle. Directly relevant to you as a Spain-based EUR investor — this is your home currency returning growth. No USD FX risk.
Thesis Breakers
  • European recession (energy shock, German industrial decline)
  • EUR structural weakness vs. USD (reduces purchasing power)
  • ASML export controls — Netherlands semiconductor equipment restrictions
  • UK political/trade divergence post-Brexit weighing on 22% weight
Macro Sensitivity
DriverEffect
ECB rate decisionsCuts = ↑
EUR/USDEUR ↑ = good for EUR investor
Defense budgets (continent-wide)↑ Strong
Energy prices (Shell, Total)Mixed
German industrial outputModerate driver (13% weight)
Overlap with Watchlist
DAX (subset — top 40) MSCI World (~15% European names) ACWI (~13% European) Defense ETF (~5% names match)

Low overlap with US-heavy ETFs. This provides genuine geographic diversification. The only EUR-denominated broad market option in the list.

Action
Phase 3+ — Strong EUR Diversifier

As a Spain-based EUR earner, this is uniquely valuable — your salary and living costs are EUR, so EUR-denominated equity returns compound without currency drag. Consider in Phase 3 alongside one US-focused core index.

Xtrackers DAX UCITS ETF 1C
LU0274211480  ·  Core · Phase 3+
TradingView: DBXD.DE (EUR/Xetra)
What It Is
IndexDAX — 40 largest German companies by market cap
Holdings40 (full replication)
TER0.09% p.a. — near cheapest
AUM€6.79B
Geography100% Germany
DAX NoteTotal return index — dividends reinvested in index itself
Top Holdings
SAP ~14% Siemens ~8% Allianz ~7% Deutsche Telekom ~6% Airbus ~5% Infineon ~5% BMW, Volkswagen, BASF, Merck KGaA

SAP alone is 14% of this ETF. High concentration in auto (BMW/VW), industrial (Siemens/Infineon), and chemicals (BASF). Very different profile from US ETFs.

Price Context (EUR, DBXD.DE)
52W Low (Feb data)~€179.76
52W High (Feb data)~€239.10
As of Feb 20~€235.05
NoteData from Feb 2026 — check DBXD.DE in TradingView for current. DAX hit new ATH above 24,000 in 2026.
DAX vs. STOXX 600 — The Choice
40 stocks vs. 600 stocks. DAX is Germany only — higher risk/reward, less diversified. STOXX 600 is all of Europe. For a Phase 3 portfolio, STOXX 600 is almost always preferable. The only reason to hold DAX specifically: you believe Germany is in a unique recovery phase worth a concentrated bet (Zeitenwende defense, industrial renaissance). Otherwise, STOXX 600 captures DAX + the rest of Europe.
Thesis Breakers
  • German auto sector decline (EV transition wiping BMW/VW margins)
  • SAP derating (14% concentration risk — if SAP corrects, DAX corrects hard)
  • German energy crisis return (BASF, chemical sector highly energy-dependent)
Macro Sensitivity
DriverEffect
German industrial output↑ Primary
China auto demand (BMW/VW ~25% China revenue)Mixed (China slowdown)
ECB rate cuts↑ Industrial re-rating
Energy prices↑ Costs for BASF/Chemicals
Defense spending (Airbus/Rheinmetall)↑ Strong
Overlap with Watchlist
STOXX 600 (DAX is ~13%) MSCI World (German names ~2–3%) Defense ETF (Airbus, Rheinmetall)

Holding STOXX 600 AND DAX = double-counting German names. Choose one or the other.

Action
Phase 3+ — Evaluate vs. STOXX 600

Lower priority than STOXX 600 unless you develop a specific Germany conviction thesis. 40-stock concentration increases single-country risk significantly. SAP at 14% is a silent bet on one company.

Amundi MSCI Emerging Markets UCITS ETF
LU1681045370  ·  Core · Phase 3+
TradingView: PAEM.PA (EUR/Euronext)
alt: AUEM.L (USD/LSE)
What It Is
IndexMSCI Emerging Markets — 24 EM countries
Holdings~1,400
TER0.20% p.a. (competitive)
AUM~€5–6B
GeographyChina 27% · India 18% · Taiwan 18% · Korea 12%
TypeAccumulating
Top Holdings
TSMCSamsung TencentAlibaba Reliance IndustriesInfosys PDD HoldingsHyundai

TSMC appears here AND in Semiconductors ETF. China ~27% = geopolitical concentration risk.

Price Context (EUR — check PAEM.PA)
EM Index (XMME reference)52W: €49.35–€75.14
Current EM (Apr 21)~€73.99
NotePrice is for similar EM ETF — verify PAEM.PA current price in TR.
Thesis
India as a decade-long growth thesis: young workforce, digital adoption, manufacturing shift from China. Taiwan: semiconductor dominance (TSMC). India overtook China as largest EM weight driver by growth. The China 27% is the risk — but if India/SE Asia continues outperforming, EM index rebalances toward it over time. This is the most volatile core position but highest potential return from EM exposure.
Thesis Breakers
  • China property/banking crisis — 27% weight drag on everything
  • Taiwan invasion scenario — TSMC would be inaccessible or destroyed
  • EM currency crises — BRL, INR, KRW weakness crushing EUR returns
  • USD structural strength — EM debt denominated in USD becomes expensive
Macro Sensitivity
DriverEffect
China economic dataMajor (27% weight)
India GDP growth↑ Growing driver
USD strength↓ EM debt costs rise
Fed rate hikes↓ Capital flight from EM
Commodity prices↑ Many EM = commodity exporters
Geopolitics (Taiwan)↓ Black swan risk
Overlap with Watchlist
ACWI (EM component) Semiconductors (TSMC/Samsung) AI & Big Data (some EM names)

If you hold ACWI, you already have ~10–11% EM exposure. Holding EM separately on top of ACWI = doubling the EM bet. Only add separately if you want explicit EM overweight.

Action
Phase 3+ — Optional EM Overweight

Skip if holding ACWI. Add if holding MSCI World and wanting explicit EM exposure. Phase 3 decision: World + EM separately (customized tilt), or ACWI (built-in EM). Don't stack both routes.

Sector — Tech Waiting

15–20% Pullback Trigger All Near ATH

All 5 tech ETFs are near 52-week highs or ATH. Entry trigger: 15–20% pullback from current levels. Current macro context (tech near ATH, semis on 17-day record rally) confirms: watching only.

iShares MSCI Global Semiconductors UCITS ETF
IE000I8KRLL9  ·  Tech — Watching
TradingView: SEMI.AS (USD/Amsterdam)
alt: IUSQ.DE (EUR/Xetra)
What It Is
IndexMSCI ACWI IMI Semiconductors & Semi Equipment (ESG)
Holdings~60–80
TER0.35% p.a.
AUM€2.96B
Includes EMYes — Taiwan (TSMC), Korea (Samsung) included
ESG ScreenedRemoves controversial weapons, tobacco etc.
Top Holdings
TSMC ~17% NVIDIA ~14% Broadcom ~9% ASML ~7% Samsung ~5% QualcommTIAMD Applied MaterialsKLA

NVIDIA + TSMC + Broadcom = ~40% of this ETF. High concentration in 3 names.

Price Context (USD, SEMI.AS)
52W Low$6.15
52W High$17.06
Current (Apr 28)~$16.17 (near ATH)
From 52W High−5.2%
Position in Range93%
Entry trigger$13.60–14.50 (15–20% pullback)

17-day record rally per macro context. 52W range of $6.15→$17.06 indicates the semis rally was enormous this year. Near ATH — no entry.

Thesis
AI compute demand → infinite semiconductor demand. TSMC is building every AI chip on the planet. Data centers need NVIDIA GPUs, networking chips (Broadcom), memory (Samsung). Sovereign AI programs in every major country (Europe, Middle East, Asia) create multi-decade capex cycle. Semis are the physical infrastructure of the AI age. Timeframe: 5–15 years structural. Near-term: volatile.
Thesis Breakers
  • Taiwan invasion scenario — TSMC shut down → semis ETF collapses
  • AI compute efficiency breakthrough reduces chip demand (DeepSeek-style disruption at scale)
  • US export controls escalate, cutting ASML/TSMC access to China markets
  • Semiconductor cycle downturn (inventory glut historically every 3–4 years)
Macro Sensitivity
DriverEffect
AI capex spending↑↑ Dominant
Data center buildout↑ Strong
US-China tech war↓ ASML/Taiwan exposure
VIX spike (high-beta)↓↓ Sells off hard
Rate hikes↓ Growth multiple compresses
NVDA earnings↑ 14% weight = major lever
Overlap with Watchlist
Nasdaq-100 (NVDA, AVGO, QCOM) S&P 500 IT (~60% names) MSCI World IT (~60% names) XAIX (~40% names) Automation/Robotics (NVDA) Amundi EM (TSMC, Samsung)
Action
Watching — Await 15–20% Pullback

Entry trigger: SEMI.AS drops to $13.60–14.50 range. Do not chase the current rally. Set a price alert on TradingView at $14.50. This is the highest-quality entry in the tech cluster — pure semiconductor exposure is cleaner than broad IT or AI/Big Data.

Maintenance Cadence

Weekly: NVDA price (proxy for semis sentiment). Monthly: TSMC earnings (most important semiconductor data point globally). Quarterly: US-China chip export control updates.

iShares S&P 500 IT Sector UCITS ETF
IE00B3WJKG14  ·  Tech — Watching
TradingView: QDVE.DE (EUR/Xetra)
alt: IUIT.L (USD/LSE)
What It Is
IndexS&P 500 IT Sector — US IT companies only
Holdings~70–80
TER0.15% p.a. — cheapest tech ETF
AUM~€4–5B
Geography100% US (S&P 500 IT sector)
GICS DefinitionSoftware, hardware, semiconductors, IT services
Top Holdings
AAPL ~22% MSFT ~22% NVDA ~20% Broadcom ~8% Oracle ~4% SalesforceCiscoAMD

AAPL + MSFT + NVDA = ~64% of this ETF. This is almost entirely a 3-stock bet.

Price Context (USD — check IUIT.L in TR)
Current StatusNear ATH (confirmed macro context)
Entry Trigger15–20% pullback from ATH
TradingViewQDVE.DE for EUR price, IUIT.L for USD
S&P 500 IT vs. Semis vs. MSCI World IT
S&P 500 IT (this): Pure US, software-heavy (AAPL + MSFT dominate). Cheapest TER (0.15%). Most concentrated in 3 names. GICS definition: includes Apple as IT company.
MSCI World IT: Adds ~15% non-US (SAP, ASML, Nintendo, Capgemini). Slightly more diversified.
Semiconductors: Pure chips/equipment play — no AAPL/MSFT software weight.
Thesis Breakers
  • Apple hardware cycle stalls (22% weight — any Apple miss hits hard)
  • Microsoft cloud growth slowdown (Azure vs. AWS/GCP competitive pressure)
  • NVIDIA earnings miss or guidance cut (20% weight)
  • Regulatory antitrust action on Big Tech
Macro Sensitivity
DriverEffect
AAPL/MSFT/NVDA earnings↑↑ Dominant (64% weight)
AI infrastructure spending↑ Strong
Rate hikes↓↓ Growth multiple compression
USD/EURUS-only exposure matters for EUR investor
Overlap with Watchlist
Nasdaq-100 (~80% same) MSCI World IT (~85% same) S&P 500 (~IT sector subset) XAIX (~55% same) Semiconductors (~50% names)

Highest overlap with most other tech ETFs. If you hold S&P 500 IT + Nasdaq-100 + XAIX simultaneously, you own AAPL/MSFT/NVDA 3 times with identical thesis.

Action
Watching — Near ATH

Lowest cost tech option (0.15%), but highest AAPL/MSFT concentration. If choosing ONE tech ETF for Phase 3+, the Semiconductors ETF has a purer thesis and less overlap with existing core positions. This is redundant if holding S&P 500 core.

Xtrackers MSCI World IT UCITS ETF 1C
IE00BM67HT60  ·  Tech — Watching
TradingView: XDWT.DE (EUR/Xetra)
What It Is
IndexMSCI World IT — IT sector across 23 developed markets
Holdings~150–200
TER0.25% p.a.
AUM~€1–2B
GeographyUS ~85% · Japan ~5% · Netherlands ~4% · Other ~6%
MSCI World IT vs. S&P 500 IT
The 15% non-US addition includes: ASML (Netherlands — critical semiconductor equipment monopoly), SAP (Germany — enterprise software), Accenture (Ireland), Nintendo (Japan), Capgemini (France). This small international addition provides geographic diversification within tech. Marginally different thesis — includes non-US tech champions.
Verdict in this Watchlist
Between S&P 500 IT and MSCI World IT, the MSCI World version is slightly preferable for an EU investor: ASML is a world-class company you're not overweighting by buying European ETFs. However, the performance difference is minimal. The real choice is: do you want IT exposure or semiconductor-specific exposure? If the latter, SEMI is better than either.
Price Context
StatusNear ATH — confirm XDWT.DE in TR
Entry trigger15–20% pullback from current
Thesis
Same as S&P 500 IT with slight geographic diversification. ASML as European tech crown jewel adds meaningful exposure to the semiconductor supply chain from the equipment side (ASML makes the machines that make the chips). ASML has a monopoly on EUV lithography — no competitor exists within a decade.
Thesis Breakers
  • ASML export controls removing China revenue (~15% of ASML sales historically)
  • US Big Tech correction (still 85% US exposure)
  • SAP cloud transition stumbles — relevant at German software weight
Macro Sensitivity

Virtually identical to S&P 500 IT. ASML adds sensitivity to EU tech regulation and Dutch export controls. SAP adds German enterprise software cycle. Marginal difference in practice.

Overlap with Watchlist
S&P 500 IT (~85% overlap) Nasdaq-100 (~75% overlap) XAIX (~55% overlap) Semiconductors (~55% overlap)
Action
Watching — Lowest Priority Tech ETF

Least differentiated of the 5 tech ETFs. If entering tech cluster, prioritize: Semiconductors (purer thesis) or AI & Big Data (broader coverage). This is a fallback option only.

iShares Automation & Robotics UCITS ETF
IE00BYZK4552  ·  Tech — Watching
TradingView: IRBO.DE (EUR/Xetra)
alt: RBOT.L (USD/LSE)
What It Is
IndexiSTOXX FactSet Automation & Robotics
Holdings~150
TER0.40% p.a. — expensive for the category
AUM€3.74B
GeographyUS ~45% · Japan ~20% · Europe ~20% · Other ~15%
DifferentiationMost geographically balanced tech ETF in list
Top Holdings
KeyenceFanuc ABBRockwell Automation Zebra TechnologiesNVIDIA Intuitive SurgicalCognex

Unique feature: heavy Japan (Fanuc, Keyence) and European (ABB, Siemens) industrial automation alongside US names. Least US-concentrated tech ETF in list.

Price Context (USD, RBOT.L)
Current (Apr 30)~$16.95
52W RangeVerify in TR (IRBO.DE)
StatusAssumed near-high given tech context
Entry Trigger15–20% pullback from current
Thesis
Physical AI: robots don't just need software, they need sensors (Keyence), precision motors (Fanuc), controllers (Rockwell, ABB). Labour cost inflation globally → automation investment acceleration. Manufacturing reshoring (US/EU/Japan) requires robotic assembly lines. This plays the physical infrastructure of automation, not the software stack. Healthcare robotics (Intuitive Surgical overlap with Healthcare Innovation) adds a defensive dimension. Timeframe: 5–10 years.
Thesis Breakers
  • Global industrial capex collapse (recession scenario)
  • Japan economic deterioration (20% weight, Keyence + Fanuc)
  • China automation imports disrupted by tariffs or sanctions
Macro Sensitivity
DriverEffect
Industrial capex spending↑ Primary
Labour cost inflation↑ Automation ROI improves
JPY strength (20% Japan)↑ Returns improve for EUR investor
Global recession↓ Capex is first cut in downturn
AI deployment acceleration↑ Physical AI buildout
Overlap with Watchlist
Healthcare Innovation (Intuitive Surgical) XAIX (NVIDIA overlap) Semiconductors (NVIDIA) DAX (Siemens)

Lowest overlap with other tech ETFs. Japan and European industrial names provide unique exposure not found elsewhere in the list. Genuinely differentiated.

Action
Watching — Most Differentiated Tech Play

Most unique of the 5 tech ETFs. Japan industrial + US robotics + European automation = exposure not replicated anywhere else in list. If entering tech cluster after pullback, this + Semiconductors is more diversified than S&P 500 IT + World IT. TER is expensive at 0.40% — account for this in long-term return calculations.

Xtrackers Artificial Intelligence & Big Data UCITS ETF 1C
IE00BGV5VN51  ·  Tech — Watching
TradingView: XAIX.DE (EUR/Xetra)
What It Is
IndexNasdaq Yewno Global Innovative Technologies
Holdings~150–200
TER0.35% p.a.
AUM€6.10B — largest AI/tech thematic ETF in Europe
GeographyUS ~70% · Europe ~15% · Asia ~10% · Other ~5%
Index MethodologyAI-selected based on patent/publication proximity to AI/data themes
Top Holdings
MicrosoftNVIDIA AlphabetAmazon PalantirCrowdStrike DatadogMongoDB SnowflakeServiceNow

Heavier on pure-play AI software (Palantir, Datadog, Snowflake) than the IT ETFs. Includes cloud infrastructure and cybersecurity. Different flavor from semiconductor or pure IT ETFs.

Price Context (EUR, XAIX.DE)
52W Low~€115.70
52W High~€156.42
Current (Apr 27)~€156.42 (AT 52W high)
From 52W High0% — AT ATH
Entry trigger€125–133 (15–20% pullback)
€115.70
€156.42
Thesis
Pure AI software and data infrastructure. The companies building the AI economy: cloud (AWS, Azure, GCP), AI platforms (Palantir's AIP), cybersecurity AI (CrowdStrike), data platforms (Snowflake, Databricks proxies). This is the software layer of the AI stack — hardware is Semiconductors, software is XAIX. Timeframe: 5–15 years. Volatile near-term.
Thesis Breakers
  • AI revenue monetization fails to materialize at scale (capex without returns)
  • Open-source AI commoditizes what closed proprietary platforms charge for
  • Cybersecurity AI breach causing regulatory crackdown on cloud providers
  • Valuation compression if rates rise significantly (growth stocks re-rate hard)
Macro Sensitivity
DriverEffect
Enterprise AI adoption rate↑↑ Primary
Cloud revenue growth↑ Strong
Rate hikes (growth multiples)↓↓ These are high-multiple companies
VIX spike↓↓ High beta tech
AI regulation (EU AI Act)Mixed — some cost, some moat
Overlap with Watchlist
Nasdaq-100 (~60% names) S&P 500 IT (~55% names) MSCI World IT (~55% names) Semiconductors (~40% names via NVDA) S&P 500 (partial)

At ATH — most dangerous entry point. The pure-play AI software names (Palantir, Datadog) are genuinely unique vs. other ETFs in the list.

Action
Watching — Hardest No Right Now

AT 52W HIGH. €156.42 — zero pullback. Set price alert at €133 in TradingView (15% below current). Do not enter. This is the most aggressive buy in the tech cluster — only enter on significant correction with clear thesis confirmation. Pair with Semiconductors if both correct together.

Sector — Watching

Low Conviction
iShares S&P 500 Financials Sector UCITS ETF
IE00B4JNQZ49  ·  Low Conviction
TradingView: QDVS.DE (EUR/Xetra)
alt: IUFS.L (USD/LSE)
What It Is
IndexS&P 500 Capped Financials — US financial sector
Holdings~70
TER0.15% p.a.
Geography100% US
GICS IncludesBanks, insurance, capital markets, consumer finance
Top Holdings
JPMorganBerkshire Hathaway VisaMastercard Bank of AmericaWells Fargo Goldman SachsMorgan Stanley
Why Low Conviction
The financials thesis is interest rate arbitrage — banks earn more in high-rate environments, but FOMC is holding at 3.5–3.75% with 4 dissenters and no cuts expected in 2026. The "higher for longer" thesis is baked in. For banks to re-rate from here, you'd need earnings beats beyond what rates already imply. There's no incremental catalyst. Additionally, S&P 500 core positions already include ~13% financials — you're getting it for free.
When Conviction Would Increase
  • → Yield curve steepening meaningfully (long rates rise, short rates fall)
  • → Credit cycle expansion (loan growth accelerating)
  • → M&A boom creating capital markets revenue surge
  • → De-regulation wave for banks
Macro Sensitivity
DriverEffect
Interest rate spread (NIM)↑ Primary
Yield curve shape↑ Steep curve = banks earn more
Credit losses / loan defaults↓ Major
Recession (loan defaults spike)↓↓ Severe
VIX / market volatility↓ Trading desk losses
Action
Watching — No Thesis Upgrade Needed

Remove from active watch unless one of the conviction catalysts above materializes. Already present at 13% in your S&P 500 core position. No incremental value right now. The grandfather watchlist does not include any financial sector names — noted.

Leveraged — Phase 4+ Only

Locked Grandfather Sign-off Required

Acknowledged, not analyzed. These instruments exist in the watchlist and will be deployed when Phase 4 conditions are met: demonstrated understanding at L5, grandfather sign-off, portfolio foundation established.

🔒
WisdomTree PHLX Semiconductor 3x Daily Leveraged ETP
XS3091657729  ·  Grandfather watchlist: SOXL EU equivalent
3x daily leverage on PHLX Semiconductor Index. EU UCITS-compliant equivalent to SOXL. Unlocks when: L5 learning level + first leveraged position live + grandfather sign-off. VIX rule: no entry above 35.
🔒
WisdomTree Nasdaq-100 3x Daily Leveraged ETP
IE00BLRPRL42  ·  EU TQQQ equivalent
3x daily leverage on Nasdaq-100. EU equivalent of TQQQ. Same unlock conditions as above. Note: 3x leveraged ETPs experience volatility decay — they are NOT long-term holds. Active management required.
🔒
WisdomTree S&P 500 3x Daily Leveraged ETP
IE00B7Y34M31  ·  EU UPRO equivalent — Reference only
Reference instrument. Grandfather watchlist does not include this specifically. Included for architectural awareness of the EU leveraged ETP ecosystem.

Portfolio-Level Analysis

A — OVERLAP & REDUNDANCY MAP

The table below maps which ETFs hold the same core companies. H = High overlap (>50% same holdings by weight), M = Moderate (20–50%), L = Low (<20%), — = Same ETF or negligible.

CSPXEQQQIWDA SSACSEMIIUIT XDWTXAIXRBOT DFENHEALXDW0
CSPX (S&P 500) HH HMH HHM LLL
EQQQ (Nasdaq-100) HH HMH HHM LLL
SEMI (Semiconductors) MMM MH HMM LLL
DFEN (Defense) LLL LLL LLL LL
HEAL (Healthcare) LLL LLL LLM LL
XDW0 (Energy) LLL LLL LLL LL
NVIDIA EXPOSURE AUDIT — appears in:
S&P 500 (~6%) Nasdaq-100 (~8%) MSCI World (~5%) ACWI (~4%) Semiconductors (~14%) S&P 500 IT (~20%) MSCI World IT (~18%) XAIX (AI & Big Data) Automation & Robotics

9 out of 16 ETFs (non-leveraged) contain NVIDIA. If you hold all 9 simultaneously with equal weight, your actual NVIDIA exposure could exceed 15% of total portfolio. This is a hidden concentration risk that only shows up when you map it explicitly.

B — EXPOSURE GAPS & BLIND SPOTS
Missing ExposureSeverityIntentional?Notes
Bonds / Fixed Income Moderate Yes Growth-only phase. Appropriate for age 23 with 30+ year horizon. Revisit at 35–40.
Real Estate (REITs) Moderate Yes Real estate strategy handled via direct property investment, not REITs.
Small/Mid Cap exposure Moderate Mostly All ETFs are market-cap weighted = large-cap dominant. STOXX 600 includes some mid/small. No dedicated small-cap play.
Commodities (ex-Energy) Low Yes No gold, agriculture, base metals. Energy thesis covers oil sector. Accept for now.
Dividend/Value tilt Low Yes All accumulating ETFs, growth-weighted. Appropriate for compounding phase. TradeRepublic 2% savings fills some income role.
Latin America / Africa Low Yes Brazil exposure handled via BR market (Inter). Family businesses in BRL. EM ETF has ~5% Brazil. Intentional separation.
USD Currency Hedge Note Unresolved Most ETFs are USD-denominated but traded on EUR exchanges (unhedged). A weakening USD (DXY at 98.35 and falling) reduces EUR returns on USD ETFs. Consider EUR-hedged share classes for Core ETFs in Phase 3.
C — RISK CONCENTRATION FLAGS
Hidden NVIDIA Concentration. Holding S&P 500 + Nasdaq-100 + Semiconductors + XAIX simultaneously creates an effective NVIDIA weight of 10–15%+ in the total portfolio. Hard rule: single position never exceeds 25% of its market's capital. At portfolio level, single-stock exposure via ETF overlap needs auditing when Phase 3 launches. Map it explicitly before deploying the core ETFs.
Core ETF Overlap — Don't Hold All Four. S&P 500 + Nasdaq-100 + MSCI World + ACWI are 80–95% the same underlying companies. Holding all four does not diversify — it creates the illusion of diversification while concentrating in the same Magnificent 7. Phase 3 decision: pick ONE primary core index. The others become redundant.
!
Energy Thesis is Tactical, Not Structural. The Energy ETF (XDW0) is deployed on a time-limited catalyst (Hormuz). It is not a long-term hold like Defense or Healthcare Innovation. When Hormuz reopens or oil drops below $80, exit logic activates. Do not forget this — it's easy to treat all positions as permanent once deployed.
!
Tech Cluster at ATH — Patience Required. All 5 tech ETFs are near 52-week highs. XAIX is AT its 52W high. Semis have had a 17-day record rally. Entering any of these now violates the 15–20% pullback trigger. The waiting is the discipline. A correction will come — be ready with alerts set.
i
DXY at 98.35 — USD Weakening Favours EUR-Denominated Positions. EUR-denominated ETFs (STOXX 600, DAX, Energy in EUR) benefit from USD weakness. USD-denominated ETFs (S&P 500, Nasdaq-100, MSCI World) show lower EUR returns when USD weakens. Current macro environment favours European and EUR positions. When DXY reverses, reassess.
i
TER Disparity in the Watchlist. TER ranges from 0.07% (CSPX, Amundi STOXX) to 0.55% (VanEck Defense). Over 20 years, a 0.48% TER difference compounds to ~10% total cost difference on the same investment. Sector ETFs (Defense, Healthcare) are expensive by design — their differentiation justifies it. For core positions, minimize TER. Never pay 0.55% for an index you can get for 0.07%.
D — DEPLOYMENT SEQUENCE RECOMMENDATION

Capital available: €860.31. Three positions cleared at €215 each. €215 in cash reserve (no thesis). Recommended order based on thesis urgency and opportunity quality:

1
Xtrackers MSCI World Energy — XDW0.DE
Highest urgency. Live catalyst (Hormuz blockade active, oil $106). −15% from 52W high. Time-sensitive — deploy first while catalyst is active.
€215
2
VanEck Defense UCITS ETF — DFEN.DE
Second priority. Structural thesis (NATO expansion) is multi-year and not time-sensitive, but −13.5% from 52W high is a reasonable entry. Deploy promptly — no advantage to waiting.
€215
3
iShares Healthcare Innovation — HEAL.MI / 2B78.DE
Third. Verify current price before entry — potential pullback from Jan 2026 levels creates a better entry than expected. Least time-sensitive of the three. Defensive/secular thesis has no expiry.
€215
4
Cash Reserve — Hold
No thesis identified. Do not force an entry. Options under consideration: (a) wait for tech pullback trigger, (b) add to strongest performing position at next review, (c) await grandfather guidance. Cash is a position.
€215

Post-Deployment Portfolio State
PositionAmount% PortfolioCategory
XDW0 — Energy€21525%Sector — Tactical
DFEN — Defense€21525%Sector — Structural
HEAL — Healthcare€21525%Sector — Secular
Cash Reserve€21525%No thesis — Hold
Total€860.31100%

Note: No single position exceeds 25% of current capital → hard rule compliance confirmed. Portfolio is 100% sector ETFs — no broad index exposure yet. Core ETFs deploy in Phase 3 when own EUR capital becomes available.

E — MONITORING SYSTEM
CadenceWhat to TrackWhereTrigger Action
DAILY VIX level · Oil price (Brent) · Hormuz news · XDW0 price TradingView VIX, BNO, XDW0.DE VIX >25: size down on any new entries. Oil <$80 or Hormuz open: review Energy exit.
WEEKLY DFEN.DE, XDW0.DE, HEAL.MI prices · Tech ETF levels vs. entry triggers · DXY direction TradingView watchlist Tech ETF hits 15–20% pullback level → activate grandfather protocol before entry.
MONTHLY Portfolio balance in TradeRepublic · Progress toward +10% unlock target (~€946) · Any new instalment commitments that affect capital availability TradeRepublic + Financial Ledger chat Portfolio hits €946 → notify grandfather, prepare tranche 2 deployment thesis.
QUARTERLY Thesis review for all 3 deployed positions · NATO budget news (Defense) · IEA energy reports (Energy) · FDA calendar (Healthcare) IEA.org, NATO newsroom, FDA.gov Any thesis breaker event → reassess position. No panic selling — evaluate vs. original thesis.
TRIGGERED Grandfather signal received · VIX >35 · Hormuz reopening confirmed · Any position down >25% from entry Grandfather signal: run full grandfather protocol before executing. VIX >35: no new entries, no panic exit. Position −25%: review thesis vs. entry reasoning — exit only if thesis broken, not price.
ANNUAL Full watchlist review (add/remove ETFs) · Tax position review (Hacienda — capital gains >€1,000) · Phase progress (emergency fund → Phase 2 → Phase 3) This document + Tax chat Capital gain realised >€1,000: flag to Tax chat immediately for Hacienda timing.

TradingView Alert Setup — Price Levels
ETFTicker in TVAlert LevelAlert Type
XAIX (AI & Big Data)XAIX.DE€133.00Price drops below — entry consideration
SEMI (Semiconductors)SEMI.AS$14.50Price drops below — entry consideration
RBOT (Automation)IRBO.DE15% below currentCalculate from current price in TR
XDW0 (Energy — exit watch)XDW0.DE€45.00Price drops below — thesis review
VIXVIX25.00Price rises above — size down protocol
VIXVIX35.00Price rises above — no new entries
EXECUTIVE SUMMARY — THE NUMBERS
Deploy: Energy first → Defense → Healthcare
Hold cash: €215 — no forced entry
Watch: Tech at ATH — set alerts, wait for pullback
Remove from active watch: Financials (no thesis catalyst)
Flag for Phase 3: Pick ONE core index (IWDA recommended) — not all four
Critical rule: NVIDIA is in 9 ETFs — audit overlap before stacking tech positions